Silvergate Capital Corporation operates as a bank holding company for Silvergate Bank that provides banking products and services to business and individual clients in the United States and internationally. The company accepts deposit products, including interest and noninterest bearing demand accounts, money market and savings accounts, and certificates of deposit accounts. Its loan products comprise one-to-four family real estate loans, multi-family real estate loans, commercial real estate loans, construction loans, commercial and industrial loans, mortgage warehouse loans, and reverse mortgage loans, as well as consumer loans and other loans secured by personal property. The company also provides cash management services for digital currency-related businesses. The company was founded in 1988 and is headquartered in La Jolla, California.
IPO Year: 2025
Exchange: NYSE
Website: silvergate.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/25/2025 | $20.00 | Buy | Goldman |
| 8/25/2025 | $23.00 | Buy | BTIG Research |
| 8/25/2025 | $18.00 | Overweight | Piper Sandler |
| 8/25/2025 | $19.00 | Buy | Jefferies |
| 3/6/2023 | Neutral → Sell | Compass Point | |
| 3/6/2023 | $9.00 → $4.00 | Neutral → Underperform | Wedbush |
| 3/2/2023 | $16.00 → $10.00 | Buy → Neutral | Compass Point |
| 3/2/2023 | Neutral → Underweight | JP Morgan | |
| 3/2/2023 | $25.00 → $9.00 | Buy → Hold | Canaccord Genuity |
| 3/1/2023 | $25.00 → $16.00 | Outperform → Mkt Perform | Keefe Bruyette |
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
3 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Goldman initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $20.00
Piper Sandler initiated coverage of Shoulder Innovations with a rating of Overweight and set a new price target of $18.00
BTIG Research initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $23.00
Jefferies initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $19.00
Compass Point downgraded Silvergate Capital from Neutral to Sell
Wedbush downgraded Silvergate Capital from Neutral to Underperform and set a new price target of $4.00 from $9.00 previously
Compass Point downgraded Silvergate Capital from Buy to Neutral and set a new price target of $10.00 from $16.00 previously
JP Morgan downgraded Silvergate Capital from Neutral to Underweight
Canaccord Genuity downgraded Silvergate Capital from Buy to Hold and set a new price target of $9.00 from $25.00 previously
Keefe Bruyette downgraded Silvergate Capital from Outperform to Mkt Perform and set a new price target of $16.00 from $25.00 previously
Fastest customizable press release news feed in the world
GRAND RAPIDS, Mich., May 26, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, June 9, 2026. About Shoulder InnovationsShoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a
Generates First Quarter Net Revenue Growth of 65% Year-Over-YearGRAND RAPIDS, Mich., May 13, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the first quarter ended March 31, 2026. First Quarter Financial HighlightsGenerated net revenue of $16.7 million in the first quarter, a 65% increase over the first quarter of 2025Achieved gross margin of 77.7% for the first quarter compare
Latest Addition to I-Series Product Line Follows a Successful Limited Market Release and FDAClearance of Additional Fracture IndicationsGRAND RAPIDS, Mich., April 27, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced full commercial launch of the InSet™ I-135RFX Humeral Stem ("InSet™ I-135RFX"). The commencement of full launch follows a successful limited market release and receipt of additional FDA 5
GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domesti
Fourth Quarter Net Revenue Growth Accelerates to 65% Year-Over-YearGRAND RAPIDS, Mich., March 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the fourth quarter and full year ended December 31, 2025. Financial HighlightsGenerated net revenue of $14.4 million in the fourth quarter, a 65% increase over the prior year quarterGenerated net revenue of $47.3 million for the full y
GRAND RAPIDS, Mich., March 2, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the appointment of Drew Hykes to the company's Board of Directors ("Board") and as a member of the Compensation Committee, effective February 26, 2026. Concurrent with Mr. Hykes's appointment, Geoff Pardo will resign as an Independent Director from the Board. "Drew is a proven healthcare leader, and we are thrilled to welcome him to S
GRAND RAPIDS, Mich., Feb. 18, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will present at the Canaccord Genuity 2026 Musculoskeletal Conference. The presentation will take place at 2:00 p.m. CT / 12:00 p.m. PT on Tuesday, March 3, 2026. A live and archived version of the presentation will be available on the "Investor Relations" section of the Shoulder Innovations website at https
GRAND RAPIDS, Mich., Feb. 12, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the fourth quarter and full year of 2025 after market close on Tuesday, March 10, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on March 10, 2026. Those interested in listening to the conference call may do so by dialing (877) 40
GRAND RAPIDS, Mich., Feb. 3, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT on Tuesday, February 10, 2026 and Wednesday, February 11, 2026. About Shoulder InnovationsShoulder Innovations is a commercial-stage medical technology company exclusivel
MARLTON, N.J., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced today the appointment of Richard J. Buchholz as its new Chief Financial Officer (CFO), effective March 2, 2026. "Rick is an accomplished executive with a proven track record in the medical device industry," said Jason Spees, Chief Executive Officer at Impulse Dynamics®. "I am thrilled to welcome Rick to the Impulse Dynamics® team at a time when we are poised for our next phase of growth as we continue to advance our mission of improving patients' lives." Buchholz most recently served as the CFO for Inspire Medi
10-Q - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
DEF 14A - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
DEFA14A - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
S-8 - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
10-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)
Live finance-specific insights
Generates First Quarter Net Revenue Growth of 65% Year-Over-YearGRAND RAPIDS, Mich., May 13, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the first quarter ended March 31, 2026. First Quarter Financial HighlightsGenerated net revenue of $16.7 million in the first quarter, a 65% increase over the first quarter of 2025Achieved gross margin of 77.7% for the first quarter compare
GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domesti
Fourth Quarter Net Revenue Growth Accelerates to 65% Year-Over-YearGRAND RAPIDS, Mich., March 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the fourth quarter and full year ended December 31, 2025. Financial HighlightsGenerated net revenue of $14.4 million in the fourth quarter, a 65% increase over the prior year quarterGenerated net revenue of $47.3 million for the full y
GRAND RAPIDS, Mich., Feb. 12, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the fourth quarter and full year of 2025 after market close on Tuesday, March 10, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on March 10, 2026. Those interested in listening to the conference call may do so by dialing (877) 40
GRAND RAPIDS, Mich., Oct. 20, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the third quarter of 2025 after market close on Tuesday, November 11, 2025. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on November 11, 2025. Those interested in listening to the conference call may do so by dialing (877) 407-8216 fo
Company to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on the Same Day GRAND RAPIDS, Mich., Aug. 28, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the second quarter of 2025 before market open on Tuesday, September 9, 2025. On the same day, members of management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Hea
Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced that the Company has suspended the payment of dividends on its 5.375% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A, in order to preserve capital. This decision reflects the Company's focus on maintaining a highly liquid balance sheet with a strong capital position as it navigates recent volatility in the digital asset industry. The Company continues to maintain a cash position in excess of its digital asset customer related deposits. The Company's Board of Directors will re-evaluate th
Silvergate Capital Corporation ("Silvergate" or "Company") (NYSE:SI) and its wholly-owned subsidiary, Silvergate Bank ("Bank"), today announced financial results for the three and twelve months ended December 31, 2022. Fourth Quarter 2022 Commentary During the fourth quarter of 2022, the digital asset industry experienced a transformational shift, with significant over-leverage in the industry leading to several high-profile bankruptcies. These dynamics created a crisis of confidence across the ecosystem and led many industry participants to shift to a "risk off" position across digital asset trading platforms. In turn, the Company saw significant outflows of deposits during the quarter a
Company to Host Conference Call Today at 8:00 a.m. ET to Discuss Recent Developments Silvergate Capital Corporation ("Silvergate" or the "Company") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced select unaudited and preliminary financial metrics for the three months ended December 31, 2022 and provided a business update. These metrics are subject to change in connection with conducting and completing normal closing procedures and an audit for the year ended December 31, 2022. The Company will also host a conference call at 8:00 a.m. (Eastern Time) today, January 5, 2023, to discuss certain recent developments.
Silvergate Capital Corporation ("Silvergate" or the "Company") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced that it will release select unaudited and preliminary fourth quarter 2022 financial metrics before market open on Thursday, January 5, 2023, with a conference call to follow at 8:00 a.m. (Eastern Time). The conference call can be accessed live by dialing 1-844-200-6205, or for international callers 1-929-526-1599, and entering the access code 712040. A replay will be available starting at 10:00 a.m. (Eastern Time) on January 5, 2023 and can be accessed by dialing 1-866-813-9403, or for international ca
Live Leadership Updates
GRAND RAPIDS, Mich., March 2, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the appointment of Drew Hykes to the company's Board of Directors ("Board") and as a member of the Compensation Committee, effective February 26, 2026. Concurrent with Mr. Hykes's appointment, Geoff Pardo will resign as an Independent Director from the Board. "Drew is a proven healthcare leader, and we are thrilled to welcome him to S
Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced the promotion of Ben Reynolds to President, and appointment of Kate Fraher as Chief Risk Officer, of both the Company and its subsidiary, Silvergate Bank. In their new roles, Ben and Kate will continue reporting to Alan Lane, CEO of Silvergate and the bank. "We are excited about these new roles, which will benefit Silvergate as we continue to grow and mature as an organization," said Alan Lane, CEO of Silvergate. "Serving the digital asset industry requires that we continue to innovate and deliver prod
Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced the appointment of Mary-Margaret Henke to the board of directors of both the Company and its subsidiary bank, Silvergate Bank. "I am fortunate to be joining Silvergate's board during this period of continued evolution for both the bank and the digital assets industry," said Mary-Margaret Henke. "I look forward to working in tandem with my fellow Board members and management to ensure the Company remains a leader in innovative banking solutions." "Mary-Margaret's extensive knowledge of the financial
Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced the appointment of Rebecca Rettig to the board of directors for both the Company and its subsidiary bank, Silvergate Bank. "I am honored to join Silvergate's board at this moment of evolution in the bank's history and the digital asset ecosystem," said Rebecca Rettig. "I look forward to working with Silvergate's leadership and my fellow board members to strengthen the Company's leadership position in this evolving and innovative industry." "Rebecca's broad wealth of knowledge in the blockchain and
This live feed shows all institutional transactions in real time.
SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)
SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)
SC 13G - Silvergate Capital Corp (0001312109) (Subject)
SC 13G - Silvergate Capital Corp (0001312109) (Subject)
SC 13G - Silvergate Capital Corp (0001312109) (Subject)
SC 13G - Silvergate Capital Corp (0001312109) (Subject)
SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)
SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)
SC 13G - Silvergate Capital Corp (0001312109) (Subject)
SC 13G - Silvergate Capital Corp (0001312109) (Subject)